Market Tracker

09/02 6:05pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

During the Trading Day
6.16 -0.10 / -1.60%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.15 -0.01 / -0.16%
 
Volume: 2.4K

Today’s Trading

Previous close6.26
Today’s open6.28
Day’s range6.03 - 6.43
Volume390,761
Average volume (3 months)740,763
Market cap$138.0M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.41+4.63%
ERBERBA Diagnostics Inc-0.04-1.10%
TROVTrovagene Inc-0.35-5.99%
CGIXCancer Genetics Inc+0.12+1.35%
Data as of 4:00pm ET, 09/02/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts